RA Capital Nexus Fund II, L.P.'s Net Worth
$0
Who is RA Capital Nexus Fund II, L.P.?
RA Capital Nexus Fund II, L.P. does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include AN2 Therapeutics, Inc., Cytek Biosciences, Inc., DICE Therapeutics, Inc., Icosavax, Inc., Eliem Therapeutics, Inc., Acumen Pharmaceuticals, Inc., ARS Pharmaceuticals, Inc., Janux Therapeutics, Inc., PepGen Inc., Acrivon Therapeutics, Inc., LENZ Therapeutics, Inc., Boundless Bio, Inc., and Werewolf Therapeutics, Inc..
SEC CIK
RA Capital Nexus Fund II, L.P.'s CIK is 0001825376
Past Insider Trading and Trends
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
AN2 Therapeutics, Inc. (ANTX) Snapshot price: $1.04
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -63.50% | -3.53M |
$1.08 | -$3,807,101.52 | 2.03M |
Aug 9
| |||
Form 4
| +52.94% | 1.78M |
$9.00 | $16,000,002.00 | 5.14M |
Aug 18
| |||
Form 4
| +0.03% | 1.91K |
$7.74 | $14,330.32 | 7.55M |
Aug 3 - Aug 4
| |||
Form 4
| +0.62% | 23.22K |
$7.78 | $180,674.69 | 3.77M |
Jul 26 - Jul 27
| |||
Form 4
| +0.01% | 302 |
$7.99 | $2,412.98 | 3.75M |
Jun 21
| |||
Form 4
| +2.22% | 81.42K |
$7.95 | $647,401.86 | 3.75M |
Jun 13 - Jun 14
| |||
Form 4
|
∞
| 3.67M |
$15.00 |
—
| 3.67M |
Mar 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Cytek Biosciences, Inc. (CTKB) Snapshot price: $5.3
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +4.56% | 583.87K |
$12.31 | $7,188,925.62 | 13.38M |
Scheduled
|
Mar 14 - Mar 15
| ||
Form 4
| +5.22% | 634.64K |
$12.86 | $8,158,670.96 | 12.8M |
Scheduled
|
Mar 9 - Mar 11
| ||
Form 4
| +5.62% | 647.26K |
$12.74 | $8,248,254.64 | 12.16M |
Scheduled
|
Mar 4 - Mar 8
| ||
Form 4
| +3.99% | 441.87K |
$12.95 | $5,721,950.62 | 11.52M |
Scheduled
|
Feb 28 - Mar 2
| ||
Form 4
| +3.95% | 420.38K |
$13.23 | $5,559,664.42 | 11.07M |
Scheduled
|
Feb 23 - Feb 25
| ||
Form 4
| +5.42% | 547.38K |
$14.06 | $7,695,707.30 | 10.65M |
Scheduled
|
Feb 17 - Feb 22
| ||
Form 4
| +5.19% | 498.63K |
$14.89 | $7,426,824.59 | 10.11M |
Scheduled
|
Feb 14 - Feb 16
| ||
Form 4
|
∞
| 9.61M |
$17.00 |
—
| 9.61M |
Jul 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
DICE Therapeutics, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -7.86M |
—
|
—
|
0
|
Aug 9
| |||
Form 4
| +7.76% | 509.14K |
$29.07 | $14,798,692.96 | 7.07M |
Mar 28 - Mar 30
| |||
Form 4
| +8.22% | 498.56K |
$26.99 | $13,457,372.44 | 6.56M |
Mar 23 - Mar 27
| |||
Form 4
| +31.48% | 1.64M |
$36.50 | $59,860,000.00 | 6.85M |
Oct 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
∞
| 5.21M |
$17.00 |
—
| 5.21M |
Sep 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Icosavax, Inc. (ICVX) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -5.97M |
—
|
—
|
0
|
Feb 19
| |||
Form 4
|
∞
| 5.54K |
—
|
—
| 5.54K |
Jun 10
| |||
Form 4
| +1.57% | 184.22K |
$4.64 | $836,882.74 | 11.92M |
Mar 28 - Mar 29
| |||
Form 4
|
∞
| 5.78M |
$15.00 |
—
| 5.78M |
Aug 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Eliem Therapeutics, Inc. (ELYM) Snapshot price: $7.39
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +76.18% | 18.27M |
$3.84 | $49,952,816.64 | 42.25M |
Jun 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 19
| |||
Form 4
| +326.51% | 10.07M |
$12.50 |
—
| 13.15M |
Aug 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||